Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An International, Randomized, Double-Blind, Parallel, Placebo-Controlled, Flexible Dose Study: Evaluation of the Safety and Efficacy of Brivaracetam in Subjects (greater than or equal to 16 to 70 Years Old) Suffering From Localization-Related or Generalized Epilepsy.

Next Previous
X
Search
Trial Profile

An International, Randomized, Double-Blind, Parallel, Placebo-Controlled, Flexible Dose Study: Evaluation of the Safety and Efficacy of Brivaracetam in Subjects (greater than or equal to 16 to 70 Years Old) Suffering From Localization-Related or Generalized Epilepsy.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Apr 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Brivaracetam (Primary)
  • Indications Epilepsy; Partial epilepsies
  • Focus Adverse reactions; Registrational
  • Sponsors UCB

    • Most Recent Events

    • 05 Dec 2017 Results of pooled analysis from two phase II, six phase III and associated long-term follow-up studies presented at the 71st Annual Meeting of the American Epilepsy Society.
    • 21 Apr 2016 Pooled analysis of seizure and quality of life outcomes (n=1904) of 9 studies (NCT00175929, NCT00175825, NCT00490035, NCT00464269, NCT00504881, NCT01261325, NCT00175916, NCT00150800, and NCT01339559) were presented at the 68th Annual Meeting of the American Academy of Neurology.
    • 27 Nov 2009 Results will be presented at the 63rd Annual Meeting of the American Epilepsy Society.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top